ERIC WOLF: Open Payments
NPI 1023106093 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 38 payments from 10 companies in 2025. Trend: 2023 $972 · 2024 $778 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $205 |
| GENZYME CORPORATION | 7 | $146 |
| AstraZeneca Pharmaceuticals LP | 6 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Optinose US, Inc. | 2 | $50 |
| ABBVIE INC. | 1 | $32 |
| Amgen Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, AIRSUPRA, Xhance, TEZSPIRE, BREZTRI, UBRELVY.
Industry payments across IL — which companies pay providers there.
